Related Experiment Video
Updated: Feb 4, 2026

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
Published on: March 7, 2017
Thioredoxin Confers Intrinsic Resistance to Cytostatic Drugs in Human Glioma Cells
Bodo Haas1, Lena Schütte2,3, Maria Wos-Maganga4
1Federal Institute for Drugs and Medical Devices, Kurt-Georg-Kiesinger-Allee 3, 53175 Bonn, Germany. bodo.haas@bfarm.de.
Abstract:
Thioredoxin (Trx) overexpression is known to be a cause of chemotherapy resistance in various tumor entities. However, Trx effects on resistance are complex and depend strictly on tissue type. In the present study, we analyzed the impact of the Trx system on intrinsic chemoresistance of human glioblastoma multiforme (GBM) cells to cytostatic drugs. Resistance of GBM cell lines and primary cells to drugs and signaling inhibitors was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays. Impact of Trx inhibition on apoptosis was investigated by proteome profiling of a subset of proteins and annexin V apoptosis assays. Trx-interacting protein (TXNIP) was overexpressed by transfection and protein expression was determined by immunoblotting. Pharmacological inhibition of Trx by 1-methyl-2-imidazolyl-disulfide (PX-12) reduced viability of three GBM cell lines, induced expression of active caspase-3, and reduced phosphorylation of AKT-kinase and expression of β-catenin. Sensitivity to cisplatin could be restored by both PX-12 and recombinant expression of the upstream Trx inhibitor TXNIP, respectively. In addition, PX-12 also sensitized primary human GBM cells to temozolomide. Combined inhibition of Trx and the phosphatidylinositide 3-kinase (PI3K) pathway resulted in massive cell death. We conclude that the Trx system and the PI3K pathway act as a sequential cascade and could potentially present a new drug target.
Insights
Thioredoxin (Trx) system inhibition overcomes chemoresistance in glioblastoma multiforme (GBM) by increasing apoptosis and reducing key survival proteins. Targeting Trx and PI3K pathways offers a novel therapeutic strategy for GBM treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Thioredoxin (Trx) overexpression contributes to chemotherapy resistance across tumor types, but its role in glioblastoma multiforme (GBM) is tissue-specific.
- Understanding the Trx system's impact on intrinsic chemoresistance in GBM is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the role of the thioredoxin (Trx) system in the intrinsic chemoresistance of human glioblastoma multiforme (GBM) cells.
- To evaluate the therapeutic potential of inhibiting the Trx system, alone or in combination with other pathways, for GBM treatment.
Main Methods:
- Assessed GBM cell line and primary cell resistance to drugs using MTT assays.
- Investigated Trx inhibition effects on apoptosis via proteome profiling and annexin V assays.
- Utilized pharmacological Trx inhibition (PX-12) and TXNIP overexpression.
Main Results:
- PX-12 reduced GBM cell viability, induced active caspase-3, and decreased AKT-kinase phosphorylation and β-catenin expression.
- Trx inhibition restored sensitivity to cisplatin in GBM cells and sensitized primary cells to temozolomide.
- Combined inhibition of Trx and phosphatidylinositide 3-kinase (PI3K) pathway led to significant cell death.
Conclusions:
- The thioredoxin (Trx) system is a key mediator of chemoresistance in glioblastoma multiforme (GBM).
- Trx inhibition, particularly in combination with PI3K pathway targeting, presents a promising therapeutic strategy for GBM.
- The Trx system and PI3K pathway function sequentially, offering a novel drug target for glioblastoma treatment.
More Related Videos
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
05:29A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
Published on: March 28, 2021
Related Concept Videos
Intrinsically Disordered Proteins
Intrinsically Disordered Proteins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Intrinsic Apoptotic Pathway
Resistivity
Resistance